Delivery Order SPE2DR25D1205-SPE2DR26F0VW4
- Not listed
- The Defense Logistics Agency awarded a $2,793.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 ml pharmaceutical product, with an ultimate completion date of October 28, 2025. This non-set-aside contract represents a competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical...
- The Defense Logistics Agency awarded a $11,425.14 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with completion targeted for July 15, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $28,177.00 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on October 29, 2025, with completion targeted for October 30, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award represents pharmaceutical supply fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through...
- The Defense Logistics Agency has awarded a delivery order valued at $5,409.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical supplies. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,561.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product on August 26, 2025, with completion targeted for August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,010.60 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,190.76 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VW4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,208.18 to AmerisourceBergen Drug Corp on October 28, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical supplies, with completion scheduled for October 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of pharmaceuticals and medical supplies globally to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's supply chain. The company maintains an extensive portfolio of federal contract awards for diverse pharmaceutical products including specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Norditropin, a human growth hormone treatment, reflects the company's ongoing role as a primary vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting mechanisms designed to meet military and federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/28/25 |